Skip to content
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. And while there is […]
Putting Americans First: International prices in context Read More »
Federal Policy
Putting Americans First: No medicine is more expensive than the one patients can’t access
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the
BIO Coffee Chat looks at patient access after three years of the IRA
It has been three years since the Inflation Reduction Act (IRA) was signed into law. “We have definitively seen negative impacts on patient access,
BIO Coffee Chat looks at patient access after three years of the IRA Read More »
Psoriasis awareness: The condition is more than skin deep
Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic
Psoriasis awareness: The condition is more than skin deep Read More »
BIO experts discuss challenges and offer opportunities for developing redosable gene therapies
As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance
BIO 2025: Federal seed funding also comes with valuable advice
The federal government’s program that provides seed funding to support research by biotech startups provides much more than money, said program officials and small
BIO 2025: Federal seed funding also comes with valuable advice Read More »
BIO 2025: Legal experts break down cases against IRA price controls
Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet to have a major impact, but the cases are still ongoing
BIO 2025: Legal experts break down cases against IRA price controls Read More »
Protect IP protections, BIO 2025 panel urges
Given the essential role that intellectual property plays in the development of lifesaving scientific advances, we need to defend and strengthen policy that protects
Protect IP protections, BIO 2025 panel urges Read More »
BIO expert explains patents at DOJ and FTC listening session
Patents enable the innovation that produces new lifesaving treatments while ensuring a competitive market, the top IP expert for the Biotechnology Innovation Organization (BIO)
BIO expert explains patents at DOJ and FTC listening session Read More »
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the
A conversation with Fritz Bittenbender, new BIO Board Chair Read More »